{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T16:28:43Z","timestamp":1793550523879,"version":"4.5.0"},"reference-count":31,"publisher":"BMJ","issue":"8","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Arch Dis Child"],"accepted":{"date-parts":[[2019,3,5]]},"published-print":{"date-parts":[[2019,8]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The evidence base to guide the pharmacological management of tone and abnormal movements in cerebral palsy (CP) is limited, as is an understanding of routine clinical practice in the UK. We aimed to establish details of motor phenotype and current pharmacological management of a representative cohort across a network of UK tertiary centres.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Prospective multicentre review of specialist motor disorder clinics at nine UK centres, collecting data on clinical features and pharmacological management of children and young people (CYP) with CP over a single calendar month.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Data were collected from 275 CYP with CP reviewed over the calendar month of October 2017. Isolated dystonia or spasticity was infrequently seen, with a mixed picture of dystonia and spasticity \u00b1 choreoathetosis identified in 194\/275 (70.5%) of CYP. A comorbid diagnosis of epilepsy was present in 103\/275 (37.4%). The most commonly used medications for abnormal tone\/movement were baclofen, trihexyphenidyl, gabapentin, diazepam and clonidine. Medication use appeared to be influenced separately by the presence of dystonia or spasticity. Botulinum toxin use was common (62.2%). A smaller proportion of children (12.4%) had undergone a previous neurosurgical procedure for tone\/movement management.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>CYP with CP frequently present with a complex movement phenotype and comorbid epilepsy. They have multiple therapy, medical and surgical management regimens. Future trials of therapeutic, pharmacological or surgical interventions in this population must adequately encompass this complexity in order to be translatable to clinical practice.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/archdischild-2018-316309","type":"journal-article","created":{"date-parts":[[2019,4,4]],"date-time":"2019-04-04T17:19:56Z","timestamp":1554398396000},"page":"775-780","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":53,"title":["Pharmacological management of abnormal tone and movement in cerebral palsy"],"prefix":"10.1136","volume":"104","author":[{"given":"Daniel E","family":"Lumsden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belinda","family":"Crowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Basu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam","family":"Amin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Devlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmin","family":"DeAlwis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ram","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajib","family":"Lodh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire T","family":"Lundy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santosh R","family":"Mordekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill","family":"Cadwgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2019,4,4]]},"reference":[{"key":"2024091723501006000_104.8.775.1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-8749.2007.tb12610.x"},{"key":"2024091723501006000_104.8.775.2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.111.1.e89"},{"key":"2024091723501006000_104.8.775.3","doi-asserted-by":"publisher","DOI":"10.1017\/S0012162201002675"},{"key":"2024091723501006000_104.8.775.4","doi-asserted-by":"publisher","DOI":"10.1111\/dmcn.12865"},{"issue":"Suppl 2","key":"2024091723501006000_104.8.775.5","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/dmcn.13026","article-title":"A special supplement: findings from the Australian Cerebral Palsy Register, birth years 1993 to 2006","volume":"58","author":"Smithers-Sheedy","year":"2016","journal-title":"Dev Med Child Neurol"},{"key":"2024091723501006000_104.8.775.6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1754.2005.00687.x"},{"key":"2024091723501006000_104.8.775.7","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1111\/dmcn.13502","article-title":"Identification and measurement of dystonia in cerebral palsy","volume":"59","author":"Rice","year":"2017","journal-title":"Dev Med Child Neurol"},{"key":"2024091723501006000_104.8.775.8","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2013-307041"},{"key":"2024091723501006000_104.8.775.9","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/dmcn.13652","article-title":"Pharmacological and neurosurgical interventions for managing dystonia in cerebral palsy: a systematic review","volume":"60","author":"Fehlings","year":"2018","journal-title":"Dev Med Child Neurol"},{"key":"2024091723501006000_104.8.775.10","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S1474-4422(17)30252-1","article-title":"Clinical presentation and management of dyskinetic cerebral palsy","volume":"16","author":"Monbaliu","year":"2017","journal-title":"Lancet Neurol"},{"key":"2024091723501006000_104.8.775.11","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1111\/dmcn.13532","article-title":"Efficacy of oral pharmacological treatments in dyskinetic cerebral palsy: a systematic review","volume":"59","author":"Masson","year":"2017","journal-title":"Dev Med Child Neurol"},{"key":"2024091723501006000_104.8.775.12","unstructured":"Excellence NIfHaC. Spasticity in children and young people with non-progressive brain disorders: Management of spasticity and co-existing motor disorders and their early musculoskeletal complications. London: National Institute for Health and Care Excellence, 2012."},{"key":"2024091723501006000_104.8.775.13","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181cbcd2f"},{"key":"2024091723501006000_104.8.775.14","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/jpc.13754","article-title":"Oral medication prescription practices of tertiary-based specialists for dystonia in children with cerebral palsy","volume":"54","author":"Harvey","year":"2018","journal-title":"J Paediatr Child Health"},{"key":"2024091723501006000_104.8.775.15","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.ejpn.2016.02.003","article-title":"Medication use in childhood dystonia","volume":"20","author":"Lumsden","year":"2016","journal-title":"Eur J Paediatr Neurol"},{"key":"2024091723501006000_104.8.775.16","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-8749.1997.tb07414.x"},{"key":"2024091723501006000_104.8.775.17","doi-asserted-by":"publisher","DOI":"10.1017\/S0012162206001162"},{"key":"2024091723501006000_104.8.775.18","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1111\/j.1469-8749.2009.03483.x","article-title":"Development of the Hypertonia Assessment Tool (HAT): a discriminative tool for hypertonia in children","volume":"52","author":"Jethwa","year":"2010","journal-title":"Dev Med Child Neurol"},{"key":"2024091723501006000_104.8.775.19","doi-asserted-by":"publisher","DOI":"10.1002\/mds.23088"},{"key":"2024091723501006000_104.8.775.20","doi-asserted-by":"publisher","DOI":"10.1111\/dmcn.12262"},{"key":"2024091723501006000_104.8.775.21","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/j.1469-8749.2011.04209.x","article-title":"The Dyskinesia Impairment Scale: a new instrument to measure dystonia and choreoathetosis in dyskinetic cerebral palsy","volume":"54","author":"Monbaliu","year":"2012","journal-title":"Dev Med Child Neurol"},{"key":"2024091723501006000_104.8.775.22","first-page":"35","article-title":"Recommendations from the SCPE collaborative group for defining and classifying cerebral palsy","volume":"109","author":"Christine","year":"2007","journal-title":"Dev Med Child Neurol Suppl"},{"key":"2024091723501006000_104.8.775.23","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.ejpn.2017.04.1333","article-title":"Spasticity, dyskinesia and ataxia in cerebral palsy: Are we sure we can differentiate them?","volume":"21","author":"Eggink","year":"2017","journal-title":"European Journal of Paediatric Neurology"},{"key":"2024091723501006000_104.8.775.24","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1111\/dmcn.13452","article-title":"A systematic review of scales to measure dystonia and choreoathetosis in children with dyskinetic cerebral palsy","volume":"59","author":"Stewart","year":"2017","journal-title":"Dev Med Child Neurol"},{"issue":"Suppl 2","key":"2024091723501006000_104.8.775.25","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/dmcn.13000","article-title":"Interobserver reliability of the Australian Spasticity Assessment Scale (ASAS)","volume":"58","author":"Love","year":"2016","journal-title":"Dev Med Child Neurol"},{"key":"2024091723501006000_104.8.775.26","doi-asserted-by":"publisher","DOI":"10.1017\/S0012162206000132"},{"key":"2024091723501006000_104.8.775.27","doi-asserted-by":"publisher","DOI":"10.2340\/16501977-1082"},{"key":"2024091723501006000_104.8.775.28","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.ejpn.2015.01.003","article-title":"Interventional studies in childhood dystonia do not address the concerns of children and their carers","volume":"19","author":"Lumsden","year":"2015","journal-title":"Eur J Paediatr Neurol"},{"key":"2024091723501006000_104.8.775.29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpn.2015.09.007"},{"key":"2024091723501006000_104.8.775.30","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.ejpn.2017.03.001","article-title":"Clonidine use in the outpatient management of\u00a0severe secondary dystonia","volume":"21","author":"Sayer","year":"2017","journal-title":"Eur J Paediatr Neurol"},{"key":"2024091723501006000_104.8.775.31","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpn.2011.10.003"}],"container-title":["Archives of Disease in Childhood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/archdischild-2018-316309","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T02:51:19Z","timestamp":1726627879000},"score":1,"resource":{"primary":{"URL":"https:\/\/adc.bmj.com\/lookup\/doi\/10.1136\/archdischild-2018-316309"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,4]]},"references-count":31,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2019,7,19]]},"published-print":{"date-parts":[[2019,8]]}},"alternative-id":["10.1136\/archdischild-2018-316309"],"URL":"https:\/\/doi.org\/10.1136\/archdischild-2018-316309","relation":{},"ISSN":["0003-9888","1468-2044"],"issn-type":[{"value":"0003-9888","type":"print"},{"value":"1468-2044","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,4]]}}}